AGENT THERAPEUTIQUE CRISTALLIN
L'INVENTION CONCERNE UNE FORME POLYMORPHE DE 1-(6-ETHOXY-5-[3-ETHYL-6,7-DIHYDRO-2-(2-METHOXYETHYL)-7-OXO-2H-PYRAZOLO-[4,3-d]-PYRIMIDINE-5-YL]-3-PYRIDYLSULFONYL)-4-ETHYLPIPERAZINE. ELLE CONCERNE EGALEMENT DES FORMULATIONS PHARMACEUTIQUES RENFERMANT CE COMPOSE. APPLICATION : UTILISATION DE CE COM...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LAURENCE JAMES HARRIS 2 RICHARD ANTHONY STOREY ALBERT SHAW WOOD |
| description | L'INVENTION CONCERNE UNE FORME POLYMORPHE DE 1-(6-ETHOXY-5-[3-ETHYL-6,7-DIHYDRO-2-(2-METHOXYETHYL)-7-OXO-2H-PYRAZOLO-[4,3-d]-PYRIMIDINE-5-YL]-3-PYRIDYLSULFONYL)-4-ETHYLPIPERAZINE. ELLE CONCERNE EGALEMENT DES FORMULATIONS PHARMACEUTIQUES RENFERMANT CE COMPOSE. APPLICATION : UTILISATION DE CE COMPOSE OU DE SES FORMULATIONS POUR LE TRAITEMENT DU DYSFONCTIONNEMENT DE L'ERECTION MASCULINE.
A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazol o[4,3- d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TNSN01112A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TNSN01112A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TNSN01112A13</originalsourceid><addsrcrecordid>eNrjZJBzdHf1C1EI8XANcgxwDQ3xDAx1VXAO8gwOcfTx8fTjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxIX7BfgaGhoZGjobGRCgBAJWOIZ0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AGENT THERAPEUTIQUE CRISTALLIN</title><source>esp@cenet</source><creator>LAURENCE JAMES HARRIS ; 2 RICHARD ANTHONY STOREY ; ALBERT SHAW WOOD</creator><creatorcontrib>LAURENCE JAMES HARRIS ; 2 RICHARD ANTHONY STOREY ; ALBERT SHAW WOOD</creatorcontrib><description>L'INVENTION CONCERNE UNE FORME POLYMORPHE DE 1-(6-ETHOXY-5-[3-ETHYL-6,7-DIHYDRO-2-(2-METHOXYETHYL)-7-OXO-2H-PYRAZOLO-[4,3-d]-PYRIMIDINE-5-YL]-3-PYRIDYLSULFONYL)-4-ETHYLPIPERAZINE. ELLE CONCERNE EGALEMENT DES FORMULATIONS PHARMACEUTIQUES RENFERMANT CE COMPOSE. APPLICATION : UTILISATION DE CE COMPOSE OU DE SES FORMULATIONS POUR LE TRAITEMENT DU DYSFONCTIONNEMENT DE L'ERECTION MASCULINE.
A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazol o[4,3- d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine.</description><language>fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051110&DB=EPODOC&CC=TN&NR=SN01112A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051110&DB=EPODOC&CC=TN&NR=SN01112A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAURENCE JAMES HARRIS</creatorcontrib><creatorcontrib>2 RICHARD ANTHONY STOREY</creatorcontrib><creatorcontrib>ALBERT SHAW WOOD</creatorcontrib><title>AGENT THERAPEUTIQUE CRISTALLIN</title><description>L'INVENTION CONCERNE UNE FORME POLYMORPHE DE 1-(6-ETHOXY-5-[3-ETHYL-6,7-DIHYDRO-2-(2-METHOXYETHYL)-7-OXO-2H-PYRAZOLO-[4,3-d]-PYRIMIDINE-5-YL]-3-PYRIDYLSULFONYL)-4-ETHYLPIPERAZINE. ELLE CONCERNE EGALEMENT DES FORMULATIONS PHARMACEUTIQUES RENFERMANT CE COMPOSE. APPLICATION : UTILISATION DE CE COMPOSE OU DE SES FORMULATIONS POUR LE TRAITEMENT DU DYSFONCTIONNEMENT DE L'ERECTION MASCULINE.
A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazol o[4,3- d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBzdHf1C1EI8XANcgxwDQ3xDAx1VXAO8gwOcfTx8fTjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxIX7BfgaGhoZGjobGRCgBAJWOIZ0</recordid><startdate>20051110</startdate><enddate>20051110</enddate><creator>LAURENCE JAMES HARRIS</creator><creator>2 RICHARD ANTHONY STOREY</creator><creator>ALBERT SHAW WOOD</creator><scope>EVB</scope></search><sort><creationdate>20051110</creationdate><title>AGENT THERAPEUTIQUE CRISTALLIN</title><author>LAURENCE JAMES HARRIS ; 2 RICHARD ANTHONY STOREY ; ALBERT SHAW WOOD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TNSN01112A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LAURENCE JAMES HARRIS</creatorcontrib><creatorcontrib>2 RICHARD ANTHONY STOREY</creatorcontrib><creatorcontrib>ALBERT SHAW WOOD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAURENCE JAMES HARRIS</au><au>2 RICHARD ANTHONY STOREY</au><au>ALBERT SHAW WOOD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AGENT THERAPEUTIQUE CRISTALLIN</title><date>2005-11-10</date><risdate>2005</risdate><abstract>L'INVENTION CONCERNE UNE FORME POLYMORPHE DE 1-(6-ETHOXY-5-[3-ETHYL-6,7-DIHYDRO-2-(2-METHOXYETHYL)-7-OXO-2H-PYRAZOLO-[4,3-d]-PYRIMIDINE-5-YL]-3-PYRIDYLSULFONYL)-4-ETHYLPIPERAZINE. ELLE CONCERNE EGALEMENT DES FORMULATIONS PHARMACEUTIQUES RENFERMANT CE COMPOSE. APPLICATION : UTILISATION DE CE COMPOSE OU DE SES FORMULATIONS POUR LE TRAITEMENT DU DYSFONCTIONNEMENT DE L'ERECTION MASCULINE.
A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazol o[4,3- d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | fre |
| recordid | cdi_epo_espacenet_TNSN01112A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AGENT THERAPEUTIQUE CRISTALLIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A24%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAURENCE%20JAMES%20HARRIS&rft.date=2005-11-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETNSN01112A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |